Synergies in psychedelic-assisted therapy: a qualitative interview study of psychotherapeutic processes

This qualitative study (n=7) interviewed Swiss therapists about psychedelic-assisted therapy and found they saw psychedelics as working alongside psychotherapy rather than replacing it. Therapists described a synergy that could strengthen trust, depth and meaningful therapeutic experiences within long-term treatment.

Authors

  • Helena Aicher

Published

Frontiers in Psychiatry
individual Study

Abstract

Research on the therapeutic effects of psychedelics in psychiatry, commonly referred to as Psychedelic-Assisted Therapy (PAT), has expanded substantially in recent years. The context-dependent nature of psychedelics has sparked discussion about the importance of the psychotherapeutic environment in achieving beneficial outcomes. This study explores the contribution of psychotherapeutic factors on PAT in Switzerland, where psychedelic treatments can be implemented within long-term clinical frameworks. Seven semi-structured interviews were conducted with Swiss therapists to explore how they frame psychedelic treatments and the role of the psychotherapeutic setting in facilitating therapeutic outcomes. Thereby, individual experiences of the patients as reported by the therapists, were particularly considered. Thematic analysis identified two main themes, each with several sub-themes. The first theme revealed that while psychotherapeutic techniques are adapted to PAT, they retain similarities to non-psychedelic psychotherapy practices, supporting patients in having meaningful therapeutic experiences. The second theme describes a synergistic relationship between psychedelics and psychotherapy, amplifying underlying general psychotherapeutic factors such as trust, a sense of profundity, and the emergence of therapeutic experiences. The interviewed therapists agreed that psychedelics work as unspecific catalysts for psychotherapeutic processes, while still acknowledging the potential for psychopharmacological effects or the interaction between psychedelics and psychotherapy to create unique psychotherapeutic processes. Findings from our sample suggest that, for specific indications, incorporating psychedelics into long-term psychotherapeutic treatment may strengthen therapeutic processes. Future research could investigate the efficacy of PAT within the framework of specific psychotherapeutic modalities or in different settings, including prospective quantitative assessments of outcomes. Ultimately, clarifying mechanisms of action of PAT may help to enhance its efficacy and potentially to integrate psychedelic treatments into mainstream mental health care.

Available with Blossom Pro

Research Summary of 'Synergies in psychedelic-assisted therapy: a qualitative interview study of psychotherapeutic processes'

Blossom's Take

Psychedelic-assisted therapy has been allowed in Switzerland for many decades. This proves to be a great place to investigate to see the real-world (not in clinical trials) implementation of this therapeutic model. Unlike arguments put forth by drug developers (e.g. Compass), the therapists argue for a strong shaping by the psychotherapeutic process (vs only the drug effect).

Introduction

Interest in psychedelic-assisted therapy (PAT) has increased sharply over the past decade, with previous studies suggesting benefits for conditions such as depression, post-traumatic stress disorder, addiction, anxiety, and end-of-life distress. At the same time, there is an unresolved debate about how much of PAT’s effect comes from the psychedelic substance itself and how much comes from the psychotherapeutic context in which it is delivered. The paper situates this discussion within the idea that psychedelics are highly context-dependent and that “set and setting”, preparation, and post-session integration may be central to outcomes. It also notes that current research often gives limited attention to the therapeutic framework, even though patients in clinical and some research settings commonly receive psychological support from trained therapists. Stellmacher and colleagues therefore set out to explore how psychotherapy contributes to PAT in Switzerland, where psychedelic treatments can be delivered in long-term clinical frameworks outside formal trials. Rather than asking whether psychotherapy matters, the study asks how and why psychotherapeutic processes shape PAT, and how they interact with the psychedelic experience. The authors framed the inquiry around three possible relationships between psychedelics and psychotherapy: a mainly psychopharmacological view, a catalyst view in which psychedelics amplify psychotherapeutic processes, and the possibility that PAT constitutes a distinct class of psychotherapeutic process. The study was designed as a qualitative interview study of Swiss therapists practising PAT. This focus is particularly relevant because Swiss clinical practice allows psychedelic sessions to be integrated over extended periods into ongoing psychotherapy, offering a setting that differs from the shorter, more standardised support structures often used in trials.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Pro members can view the original manuscript directly in the browser.

Study Details

  • Study Type
    individual
  • Journal
  • Author
  • APA Citation

    Stellmacher, J., Schmidt, C., Aicher, H. D., Eichel, K., Brakemeier, E. L., & Herwig, U. (2026). Synergies in psychedelic-assisted therapy: a qualitative interview study of psychotherapeutic processes. Frontiers in Psychiatry, 17. https://doi.org/10.3389/fpsyt.2026.1771726

References (35)

Papers cited by this study that are also in Blossom

Long-term effects of psychedelic drugs: A systematic review

Aday, J. S., Mitzkovitz, C. M., Bloesch, E. K. et al. · Neuroscience and Biobehavioral Reviews (2020)

Psychedelics and Psychedelic-Assisted Psychotherapy

Reiff, C. M., Richman, E. E., Nemeroff, C. B. et al. · American Journal of Psychiatry (2020)

A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy

Luoma, J. B., Chwyl, C., Bathje, G. J. et al. · Journal of Psychoactive Drugs (2020)

168 cited
Towards an understanding of psychedelic-induced neuroplasticity

Calder, A. E., Hasler, G. · Neuropsychopharmacology (2022)

Must Psilocybin Always “Assist Psychotherapy”?

Goodwin, G. M., Malievskaia, E., Fonzo, G. A. et al. · American Journal of Psychiatry (2023)

Treatment with psychedelics is psychotherapy: beyond reductionism

Gründer, G., Brand, M., Mertens, L. J. et al. · Lancet Psychiatry (2024)

Human hallucinogen research: guidelines for safety

Johnson, M. W., Richards, W. A., Griffiths, R. R. · Journal of Psychopharmacology (2008)

Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance

Wolff, M., Evens, R., Mertens, L. J. et al. · Frontiers in Psychiatry (2020)

Show all 35 references
Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis

Hieronymus, F., López, E., Sjögren, H. W. et al. · JAMA Network Open (2025)

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up

Carhart-Harris, R. L., Bolstridge, &. M., Day, C. M. J. et al. · Psychopharmacology (2017)

Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression

Goodwin, G. M., Aaronson, S. T., Alvarez, O. et al. · New England Journal of Medicine (2022)

656 cited
Psychedelic-assisted psychotherapy: Where is the psychotherapy research?

Aday, J. S., Horton, D. M., Fernandes-Osterhold, G. et al. · Psychopharmacology (2024)

Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression

Murphy, R., Murphy-Beiner, A., Kettner, H. et al. · Frontiers in Pharmacology (2022)

162 cited
Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors

Vargas, M. V., Dunlap, L. E., Dong, C. et al. · Science (2023)

330 cited
Lower-dose psycholytic therapy - A neglected approach

Passie, T., Guss, J., Kraehenmann, R. · Frontiers in Psychiatry (2022)

Critical Period Plasticity as a Framework for Psychedelic-Assisted Psychotherapy

Yehuda, R., Lepow, L., Morishita, H. · Frontiers in Neuroscience (2021)

Adverse effects of psychedelics: From anecdotes and misinformation to systematic science

Neil, J. C., Nutt, D. J. · Journal of Psychopharmacology (2022)

Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics

Earp, B. D., Repantis, D., Langlitz, N. et al. · Frontiers in Psychiatry (2021)

28 cited
Psychedelic-Assisted Psychotherapy-A Systematic Review of Associated Psychological Interventions

Cavarra, M., Falzone, A., Ramaekers, J. G. et al. · Frontiers in Psychology (2022)

Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default

Yaden, D. B., Earp, D., Graziosi, M. et al. · Frontiers in Psychology (2022)

The use of the psychological flexibility model to support psychedelic assisted therapy

Watts, R., Luoma, J. B. · Journal of Contextual Behavioral Science (2020)

An Integrated theory of false insights and beliefs under psychedelics

McGovern, H., Grimmer, H. J., Doss, M. K. et al. · Communications Psychology (2024)

Psychedelic pleasures: An affective understanding of the joys of tripping

Bøhling, F. · International Journal of Drug Policy (2017)

The potential synergistic effects between psychedelic administration and nature contact for the improvement of mental health

Gandy, S., Forstmann, M., Carhart-Harris, R. L. et al. · Health Psychology Open (2020)

Experience of Music Used With Psychedelic Therapy: A Rapid Review and Implications

O'callaghan, C., Hubik, D. J., Psychiatry, M. et al. · Journal of Music Therapy (2020)

Ethics and ego dissolution: the case of psilocybin

Smith, W. R., Sisti, D. · Journal of Medical Ethics (2020)

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.